ARCHIVES

FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Editorial: Rumor Mill Fills The Gap When Access Denied

December 16, 1994

NCA Okays New Centers Category For Environmental Carcinogenesis

July 4, 1975

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

President’s Cancer Panel Seeks Ways to Open Grants For More New Ideas

December 19, 1980